Requirements for Fertility Preservation for Cancer Patients and Healthy Individuals

Advances in cancer awareness, early detection, diagnosis and treatment have increased survival of male and female cancer patients [1,2]. A multidisciplinary team is involved in treatment of cancer patient. The major goal of this team is to save life. However, cancer treatment may cause infertility in both males and females, thus fertility preservation is essential [3,4]. Significant advances have been made in fertility preservation of pre-pubertal, pubertal and adult patients [5,6]. Since fertility preservation facilities are not directly involved in treatment of cancer patients, their role is either inadvertently missed or patient is given a very short time for fertility preservation. Sperm, testicular tissue, oocyte, and embryo cryopreservation is done for other reasons as well [7-9]. Usually the cancer patients, healthy individuals or referring physicians are not aware of the requirements by the fertility preservation facilities which increases stress and results in delay of cryopreservation. The purpose of this opinion is to enhance awareness about requirements of the fertility preservation and to emphasize timely communication between cancer patient or healthy individual and the fertility preservation facility to reduce stress and properly safeguard future fertility. Fertility preservation, sperm cryopreservation, testicular tissue, ovarian tissue, oocyte cryopreservation


Opinion
Advances in cancer awareness, early detection, diagnosis and treatment have increased survival of male and female cancer patients [1,2]. A multidisciplinary team is involved in treatment of cancer patient. The major goal of this team is to save life. However, cancer treatment may cause infertility in both males and females, thus fertility preservation is essential [3,4]. Significant advances have been made in fertility preservation of pre-pubertal, pubertal and adult patients [5,6]. Since fertility preservation facilities are not directly involved in treatment of cancer patients, their role is either inadvertently missed or patient is given a very short time for fertility preservation. Sperm, testicular tissue, oocyte, and embryo cryopreservation is done for other reasons as well [7][8][9]. Usually the cancer patients, healthy individuals or referring physicians are not aware of the requirements by the fertility preservation facilities which increases stress and results in delay of cryopreservation. The purpose of this opinion is to enhance awareness about requirements of the fertility preservation and to emphasize timely communication between cancer patient or healthy individual and the fertility preservation facility to reduce stress and properly safeguard future fertility. Fertility preservation, sperm cryopreservation, testicular tissue, ovarian tissue, oocyte cryopreservation

General Requirements of Fertility Preservation for Male and Female
Following are general requirements that may vary among different fertility preservation facilities. is usually for one year and has to be renewed every year, however, with mutual agreement and payment of dues, the contract can be extended. However, in some situations, there may be statutory time limit for storage of gametes [10]. The responsibility of agreement renewal and updating contacts (if they change) is responsibility of patient or individual. The fertility preservation facility can't afford to keep the unpaid samples for unlimited time therefore, the samples may be disposed if contract is not renewed. Technically, the samples can be stored in liquid nitrogen for a long time provided the liquid nitrogen level is maintained regularly [11,12]. Most of the damage to the sample happens at cryopreservation or warming.

Cryopreservation Consent and Storage
With the advent of vitrification, post-warming survival of eggs and embryos is reaching high limits [13]. Sperm and testicular tissue cryopreservation have been in practice for several years and are very successful procedures [14].

Results of Communicable Disease Tests
The viruses and bacteria survive in ultra-low temperature of liquid nitrogen and there is a possibility of cross contamination of samples during storage [15,16]

Number of Samples to be Cryopreserved
The number of samples to be cryopreserved depends on number of children desired, type and quality of the sample. Fertility counselor and the fertility preservation facility can provide some guidance, but the final decision is to be made by the cancer patient or the healthy individual.

Options for Male
a) The male capable of producing semen, usually 48 h abstinence is recommended in between 2 ejaculates. Shorter abstinence [17] [19]. These procedures involve a fertility surgeon and anesthesiologist in addition to fertility preservation laboratory, therefore, appointment should be booked as soon as possible. Testicular tissue cryopreservation is successful, and many births have been achieved utilizing sperm retrieved from frozen-thawed testicular tissue [20].

Options for Female
a) Oocyte cryopreservation is now commonly applied procedure [9]. It is the only option for unmarried females.
Oocytes can be collected trans-abdominally [21] instead of trans-vaginally. The success rate depends on age of patient and quality and maturity of oocytes. The oocytes can be collected twice during one menstrual period [22]. The number of oocytes to be frozen depends on age, ovarian reserve, future plans and quality of sperm to be used.

Figure 1:
In male, the cell to be cryopreserved is "sperm" which can be obtained from ejaculate, from epididymis or the seminiferous tubules in testes. b) Embryo freezing is an option for married females. Very high embryo survival rate [13] and high pregnancy rate [23] can be expected depending on age of female. The embryos can be frozen on day 3 or day 5 depending on choice of the individual, reproductive endocrinologist and the fertility preservation laboratory.

c)
For female cancer patients, ovarian tissue cryopreservation has been done successfully [24]. There is possibility of re-introduction of cancer on re-implantation of the tissue. In vitro follicular culture, in vitro oocyte maturation [25] and use of synthetic ovary are still experimental and not available clinically. Figure 2 shows female reproductive system explaining source of oocytes which has to be preserved to secure fertility.

Conclusion
Fertility preservation is becoming increasingly important not only for cancer and infertile patients but also for healthy individuals.
Fertility preservation facilities may have different requirements and capabilities to preserve gametes, embryos and tissues. It is highly important to communicate in advance with the fertility preservation facility to reduce stress and delays in preservation.
The gamete or tissue owner is recommended to direct the future use of their gametes or tissues.